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Mitochondria are the principal targets in the development of ischemia-reperfusion
(I/R) induced hepatic injury (1, 2). Increased production of superoxide radicals at the
level of the mitochondrial respiratory chain is allegedly a major participant in I/R injury
(2). Oxidant stress induced cell killing involves oxidation of pyridine nucleotides, accu-
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Ca2+ accumulation and Ca2+ overloading in mitochondria
are responsible for the cell abnormality associated with
ischemia and reperfusion injury. The present study was
aimed at evaluating the efficacy of the Ca2+ channel blo-
cker amlodipine on the mitochondrial Ca2+ accumulation,
mitochondrial antioxidant status and mitochondrial re-
spiratory enzymes in ischemia and reperfusion (I/R) in-
duced liver injury. I/R injury induced mitochondrial da-
mage in rats was assessed in terms of the decrease in
activities (p < 0.05) of respiratory marker enzymes (malate
dehydrogenase, succinate dehydrogenase and NADH de-
hydrogenase), mitochondrial antioxidant enzymes (gluta-
thione, superoxide dismutase, catalase), and significant in-
crease (p < 0.05) in the level of lipid peroxidation (LPO)
and Ca2+ content.
Mitochondrial damage was confirmed by transmission
electron microscopic (TEM) examination. Pretreatment
with amlodipine effectively counteracted the alteration in
mitochondrial enzymes induced by ischemia-reperfusion
liver damage. TEM study confirms the restoration of cel-
lular normalcy and the cytoprotective role of amlodipine
against I/R induced hepatic injury. On the basis of our
findings it may be concluded that amlodipine not only
possesses Ca2+ channel antagonist properties but it may
also reduce the extent of mitochondrial damage by its an-
tioxidant activity.
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mulation of calcium ions in mitochondria, and superoxide formation by mitochondria,
ultimately leading to formation of membrane permeability transition pores and break-
down of the mitochondrial membrane potential (3), alteration of mitochondrial enzymes
activity, intracellular Ca2+ accumulation and Ca2+ overloading, contributing to irrever-
sible cell damage (4). Ischemia is associated with impaired calcium homeostasis. Ische-
mic tissue injury causes an increase in free intracellular calcium that leads to diminished
recovery of the dilation function after ischemia (vasoconstriction), compromised mem-
brane integrity and decreasing reserves of cellular adenosine triphosphate. Amlodipine
is a second-generation dihydropyridine calcium channel blocker shown to have a grad-
ual onset and sustained duration of action because of the selectivity of dihydropyridines
for the vascular smooth muscle (5). The pharmacokinetic profile such as that of amlo-
dipine may prove to be valuable in protection from the ischemica and reperfused inju-
ries. A single intravenous dose of 10 mg amlodipine resulted in absolute bioavailability of
64% and a calculated half-life of 34 hours (6). The present study evaluates the potential
effect of the calcium antagonist amlodipine on hepatic mitochondrial marker enzymes,
antioxidant and mitochondrial structure in I/R induced hepatotoxicity.
EXPERIMENTAL
Collagenase and bovine serum albumin (BSA) were purchased from Hymedia (In-
dia). Other chemicals were obtained from Sigma (USA).
Experimental design
Male Wistar rats weighing 200 to 250 g were purchased from Laboratory Animal
Resources, Indian Veterinary Research Institute, Izzatnagar, UP, India. Animals were kept
in temperature-controlled rooms at the animal house, College of Pharmacy, IFTM, Mora-
dabad, UP India, with 12 h alternating light and dark cycles and were given adequate
nutrition and water ad libitum. All experimental protocols using animals were perfor-
med according to the »Principles of Laboratory Animal Care« (NIH publication 85–23,
revised 1985). Experimental protocols were reviewed and approved by the institutional
Ethical Committee. Eighteen Wistar rats were divided into a control group (I) (n = 6),
ischemia and reperfusion group (II) (n = 6), and amlodipine pre-treated group (1 mg kg–1
body mass daily by oral route for 7 days before induced ischemia-reperfusion maneu-
ver) (III) (n = 6). Ischemia and reperfusion injury was produced as per the procedure de-
scribed by Hayashi et al. (7). In short, after the induction of anesthesia (urethane 10 mg
kg–1 body mass daily by i.p.), the liver of each animal was exposed through a midline
laparotomy. Clamping the left branches of the portal vein and the hepatic artery for 60
min produced complete ischemia of the median and left hepatic lobes. The right hepatic
lobe was perfused to prevent intestinal congestion. After the period of ischemia, the liga-
tures around the left branches of the portal vein and hepatic artery were removed. The
wound was closed with 3–0 silk. Sham-operated animals were similarly prepared except
that no ligature was placed to obstruct the blood flow to the left and median hepatic lobes.
Instead, the blood flow to the right lobe of the liver was occluded. After 3 h reperfusion,
rats were euthanized by diethyl ether (S.D. Fine Chemicals Ltd., India) and blood and
tissue samples were collected, as described below.
422
C. Pronobesh et al.: Protective role of the calcium channel blocker amlodipine against mitochondrial injury in ischemia and reperfusion
injury of rat liver, Acta Pharm. 58 (2008) 421–428.
Peripheral tissue procurement
A portion of ischemic and non-ischemic liver lobes were fixed in buffered 10% for-
malin and Karnovsky’s solution (2.5% glutaraldehyde and 2% formaldehyde in 0.2 mol
L–1 phosphate buffer) for histopathology and TEM studies. Another portion of ischemic
and non-ischemic liver lobes were snap frozen in liquid nitrogen and stored for 3 days at
–70 °C for mitochondria isolation.
Isolation of mitochondria
The liver mitochondria were isolated by the method of Johnson and Lardy (8). A
portion of liver tissue was weighted and homogenized with 0.35 mol L–1 sucrose buffer
at 4 °C and centrifuged at 10,000´g for 5 minutes. The resultant mitochondrial pellet was
then resuspended in 0.25 mol L–1 sucrose solution containing 10 mmol L–1 Tris-HCl (pH
7.4) and 1 mmol L–1 EDTA up to a final volume of 2 mL. Mitochondrial integrity of the
hepatocytes was measured by reduction of mitochondrial enzyme succinate dehydro-
genase using the 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) as-
say as described by Barltrop et al. (9).
Assay of enzymes
The mitochondrial respiratory marker enzymes such as malate dehydrogenase (MDH),
succinate dehydrogenase (SDH), NADH dehydrogenase and mitochondrial antioxidants
such as glutathione-S-transferase (GST), superoxide dismutase (SOD), catalase (CAT)
and mitochondrial lipid peroxides (LPO) were determined as described previously by
Mehler et al. (10), Slater and Bonne (11), Minakami et al. (12), Habig et al. (13), Hodgson
and Fridovich (14), Takahara et al. (15) and Ohkawa et al. (16), respectively. Mitochon-
drial calcium was estimated by using the diagnostic kit (Quiligens Diagnostics, India)
according to manufacturer’s guidelines.
Transmission electron microscopy (TEM) of liver tissue
Liver tissue was fixed in Karnovsky’s solution pH 7.4 for 4 h at 4 °C. After fixation
and an overnight wash in sodium cacodylate buffer at 4 °C, the specimens were post-
fixed with 1 % osmium tetroxide in 0.1 mol L–1 phosphate buffer (pH 7.4), dehydrated in
ethanol and then embedded in Araldite resin (Ducupan, Fluka BioChemika, USA). Semi-
-thin sections (1 mm) were cut for optical microscopy. Ultra-thin sections (40–60 nm) were
placed on copper mesh grids (200 nm) and double-stained with uranyl acetate and lead
citrate. Sections were examined using a transmission electron microscope (Moragagni 268
D, The Netherlands) and photomicrographs were taken.
Statistical analysis
All values were expressed as mean ± SD. Differences in mean values were compa-
red by one-way ANOVA and Student-Newman-Keul (SNK) test.
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RESULTS AND DISCUSSION
The activities of mitochondrial respiratory, viz. malate dehydrogenase (MDH), su-
ccinate dehydrogenase (SDH) and NADH dehydrogenase (NADH), marker enzymes were
significantly decreased (p < 0.05) in the I/R liver injured group of rats compared to the
control group (Table I). Pretreatment with amlodipine (group III) reverted the altered acti-
vities of these enzymes to near control levels when compared to the sham-operated con-
trol group (Table I).
The activity of mitochondrial antioxidant enzymes, viz. glutathione-S-transferase
(GST), superoxide dismutase (SOD), catalase (CAT), was significantly (p < 0.05) decreased
while Ca2+ content and lipid peroxides (LPO) activity was increased significantly (p <
0.05) in the I/R injured group of rats compared to the control group (Table II). Activities
of these enzymes in mitochondria were almost completely reversed in the amlodipine
pretreated group of rats (Table II). Pretreatment with amlodipine also prevented lipid
peroxidation compared to the I/R liver injured group of animals.
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Table. I. Activities of mitochondrial and respiratory enzymes in the liver of control
and experimental groups of rats
Group MDHa SDHb NADH dehydrogenasec
Control 293.12 ± 25.34 201.40 ± 17.65 124.36 ± 19.65
I/R Injury 187.25 ± 33.51d 112.87 ± 13.46d 85.63 ± 5.61f
Amlodipine + I/R injury 249.70 ± 27.18e 182.32 ± 24.50e 108.44 ± 17.49g
Results are expressed as mean ± SD (n = 6).
a Expressed as nmol of MDH oxidized per min per mg protein.
b Expressed as nmol of succinate oxidized per min per mg protein.
c Expressed as nmol NADH oxidized per min per mg protein.
Significantly different from control group (d p < 0.05, f p < 0.01).
Significantly different from I/R injury group (e p < 0.05, g p < 0.01).
Table II. Activities of mitochondrial antioxidant enzymes, Ca+2 content and LPO in the liver
of control and experimental groups of rats
Group GSTa SODb CATc LPOd Ca2+e
Control 64.37 ± 5.90 15.41 ± 1.34 1.32 ± 0.19 4.10 ± 0.60 7.11 ± 0.39
I/R Injury 40.29 ± 4.87f 4.98 ± 0.91h 0.94 ± 0.08h 7.25 ± 0.33f 12.36 ± 1.54f
Amlodipine + I/R injury 60.87 ± 5.19g 13.22 ± 1.47i 1.30 ± 0.46g 3.49 ± 0.47i 8.70 ± 1.22i
Results are expressed as mean ± SD (n = 6).
a Expressed as nmol of 1-chloro 2,4-dinitrobenzene (CDNB) oxidized per min per 100 mg protein.
b Expressed as units per min per 100 mg protein.
c Expressed as nmol of H2O2 decomposed per min per mg protein.
d Expressed as nmol of MDA per mg of protein.
e Expressed as nmol per mg of protein.
Significantly different (f p < 0.05, h p < 0.01) from control group.
Significantly different (g p < 0.05, i p < 0.01) from I/R injury group.
Transmission electron microscopy (TEM) studies showed that the I/R injured rats
mitochondria of hepatocytes were severely swollen with less quantity and cristae. Pre-
treatment with amlodipine showed improvement in cytoplasmic changes as well as the
fine ultra structure of the mitochondria similarly to the control liver section (Fig. 1).
In the present study, ischemia and reperfusion injury caused severe mitochondrial
degeneration leading to the tricarboxyl acid (TCA) cycles marker enzymes (MDH, SDH)
which were observed in I/R injured rats. The impaired mitochondrial function, which
may contribute to the pathogenesis of I/R induced hepatotoxicity, might be a reason for
activation of Kupfer cells leading to generation of reactive oxygen species (ROS).
The activity of the respiratory marker NADH dehydrogenase was lowered in I/R
rats. This could be due to enhanced phospholipids degradation and participation of ROS
in the mitochondrial electron transfer system. Pretreatment with amlodipine reduced the
extent of mitochondrial damage and reversed the activities of TCA cycle and respiratory
marker enzymes towards normalcy. The enhanced oxidative stress and mitochondrial
calcium overload have been taken to be responsible for mitochondrial dysfunction (17).
We observed an increase in the level of calcium in the mitochondria in I/R induced he-
patocytes. Pretreatment with amlodipine prevented the increase in mitochondrial Ca2+
concentration, thereby restoring the mitochondrial function.
In the cellular defence system, GSH (reduced glutathione) plays an important pro-
tective role, as an intracellular free radical scavenger, by conjugation with metabolites,
and also protects the mitochondrial membrane from the damaging action of LPO (18).
Low level of GSH was observed during increased oxidative stress caused by I/R. Cellu-
lar GSH depletion is closely related to the lipid peroxidation and disturbance of Ca2+ in-
flux induced by oxidative injury (19). This observation supports our findings where we
observed a decline in GST levels in I/R injured rats. Pretreatment with amlodipine in
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a) b)
c) Fig. 1. TEM analysis of liver sections following
I/R: a) control liver section showing normal cell
architecture with a prominent nucleus and well
defined cell wall and cell membrane, b) group II
liver section showing that mitochondria were se-
verely swollen and had a reduction in the num-
ber of cristae, c) group III liver section showing
similarities (well defined nucleus with small
swollen mitochondria) with the control group
(uranyl acetate and lead citrate stain, 8000 ´).
I/R rats maintained the concentration of GSH at near normal levels, which prevented
cell disruption, probably by decreasing the Ca2+ influx.
Major antioxidants like SOD, CAT and GST are important for cellular protection due
to their ability to detoxify free radicals such as ROS. A number of studies have reported
diverse results for the changes of these antioxidant enzyme activities in I/R induced he-
patic injury (20). Accentuated mitochondrial lipid peroxidation, accompanied by a dete-
riorating mitochondrial antioxidant status is evident in I/R injured rats. The rise in the
activities of mitochondrial antioxidant enzymes in amlodipine pretreated group high-
lights the protective role of amlodipine in combating the oxidative insult. Lipid peroxi-
dation is one of the major outcomes of free radical-mediated tissue injury and is an indi-
cator of oxidative damage by a series of chain reactions. Increased level of MDA, the end
product of LPO, was observed in I/R injured rats. Mitochondrial lipid peroxidation was
significantly (p < 0.05) lowered in the amlodipine pretreated group compared to the I/R
injured group. Our results are in concord with the earlier work done by Wang et al. (21),
where it was reported that amlodipine regulates membrane fluidity and cholesterol de-
positions, acts as an antioxidant and regulates matrix deposition.
Ultra structural changes were demonstrated microscopically in I/R rats. Our study
shows that, after 1 h ischemia and 3 h reperfusion, there is accumulation of Ca2+ which
leads to autophagosomes, reduction in the number of mitochondria and nuclear conden-
sation. Pretreatment with amlodipine showed considerable prevention in the ultra struc-
tural alteration, including disruption of mitochondrial and nuclear fine structures. Both
Ca2+ accumulation and oxidative stress increase the probability of changes in mitochon-
drial permeability and together with opening the transition pore in the mitochondria carry
the signals for cell death (22). Amlodipine prevents cellular damage in the membrane
probably by inhibiting the calcium channel of hepatocytes. A previous study reported
that amlodipine reduced hepatic I/R injury by cytoprotective effects on parenchymal and
non-parenchymal hepatocytes during both preservation and reperfusion (23). Other Ca2+
channel antagonists, verampril (24) and nimodipine, are also reported to have a protec-
tive role in hepatic I/R induced injury. Thus, the present study, consistent with our pre-
vious study, provides evidence that amlodipine protects I/R rats from mitochondrial in-
jury, giving an insight into the underlying mechanisms of the effects of amlodipine.
CONCLUSIONS
The present investigation suggests that the protective action of amlodipine, a cal-
cium channel blocker, against the I/R induced liver injury in rats is due to its inhibitory
action on Ca2+ influx into the mitochondria and probably to its antioxidant property.
Additional studies are needed to determine whether there is a link between reductions
in the I/R induced injury liver markers as achieved with calcium antagonists and that
obtained with oxygen radical scavengers.
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S A @ E T A K
Za{titna uloga amlodipina, blokatora kalcijevih kanala, protiv o{te}enja
mitohondrija kod ishemi~nih i reperfuzijskih ozljeda jetre {takora
CHATTOPADHYAY PRONOBESH, AHER VAIBHAV, CHAUDHURY PALLAB i WAHI ARUN KUMAR
Akumulacija Ca2+ iona i njihovo nakupljanje u mitohondrijima uzrok je abnormal-
nosti u stanicama nakon ishemi~nih i reperfuzijskih ozljeda. Cilj ovog rada bio je ispitati
u~inak amlodipina, blokatora kalcijevih kanala, na nakupljanje iona kalcija u mitohond-
rijima, antioksidativni status mitohondrija i na aktivnost enzima u di{nom lancu kod ishe-
mi~nih i reperfuzijskih (I/R) ozljeda jetre. Kod tih ozljeda smanjeno je djelovanje (p <
0,05) enzima di{nog lanca (malat dehidrogenaze, sukcinat dehidrogenaze i NADH-dehi-
drogenaze), antioksidativnih enzima mitohondrija (glutation, superoksid dismutaze, ka-
talaze), stupanj lipidne peroksidacije (LPO) i nakupljanje iona Ca2+.
O{te}enje mitohondrija potvr|eno je transmisijskom elektronskom mikroskopijom
(TEM). Prethodna obrada s amlodipinom u~inkovito sprje~ava promjenu aktivnosti en-
zima mitohondrija uzrokovanih I/R o{te}enjima jetre. TEM potvr|uje uspostavljanje nor-
malnih uvjeta u stanici i citoprotektivno djelovanje amlodipina. Na temelju rezultata na-
{ih istra`ivanja mo`e se zaklju~iti da amlodipin zbog antioksidativnog djelovanja reducira
o{te}enje mitohondrija.
Klju~ne rije~i: blokator kalcijevih kanala, amlodipin, ishemi~na i reperfuzijska ozljeda, o{te}enje
mitohondrija
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